Our predoctoral researcher Lucía del Pozo participated in the ENCALS 2025 congress (European Network to Cure ALS), held in Turin, Italy, where she presented her work in poster format.
The study, titled: “Repositioning protective analysis of Glutamic Oxaloacetic Transaminase 1 (GOT1) treatment for Amyotrophic Lateral Sclerosis,”
explores the therapeutic potential of the GOT1 enzyme in Amyotrophic Lateral Sclerosis (ALS).
